Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Anderson

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
Heart Rhythm|September 29, 2005
"We are not alone": ion channel mutations in a long QT syndrome cohortMark E Anderson
Trends in Cardiovascular Medicine|June 5, 2004
Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias?Mark E Anderson
Pharmacology & Therapeutics|March 23, 2005
Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmiasMark E Anderson
Journal of Cardiovascular Electrophysiology|July 14, 2006
Too little, too late: chasing atrial fibrillation with sodium channel antagonistsMark E Anderson
Cardiovascular Research|January 27, 2007
Multiple downstream proarrhythmic targets for calmodulin kinase II: moving beyond an ion channel-centric focusMark E Anderson
JAMA Cardiology|April 14, 2021
To Be or Not to Be a CaMKII Inhibitor?Mark E Anderson
Heart Rhythm|June 9, 2007
When will we know enough to treat atrial fibrillation?Mark E Anderson
The Journal of Clinical Investigation|May 8, 2009
CaMKII and a failing strategy for growth in heartMark E Anderson
Circulation Research|September 14, 2013
Why has it taken so long to learn what we still don't know?Mark E Anderson
Journal of Molecular and Cellular Cardiology|December 28, 2016
CaMKII is a nodal signal for multiple programmed cell death pathways in heartNing Feng, Mark E Anderson
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
Heart Rhythm|September 29, 2005
"We are not alone": ion channel mutations in a long QT syndrome cohortMark E Anderson
Trends in Cardiovascular Medicine|June 5, 2004
Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias?Mark E Anderson
Pharmacology & Therapeutics|March 23, 2005
Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmiasMark E Anderson
Journal of Cardiovascular Electrophysiology|July 14, 2006
Too little, too late: chasing atrial fibrillation with sodium channel antagonistsMark E Anderson
Cardiovascular Research|January 27, 2007
Multiple downstream proarrhythmic targets for calmodulin kinase II: moving beyond an ion channel-centric focusMark E Anderson
JAMA Cardiology|April 14, 2021
To Be or Not to Be a CaMKII Inhibitor?Mark E Anderson
Heart Rhythm|June 9, 2007
When will we know enough to treat atrial fibrillation?Mark E Anderson
The Journal of Clinical Investigation|May 8, 2009
CaMKII and a failing strategy for growth in heartMark E Anderson
Circulation Research|September 14, 2013
Why has it taken so long to learn what we still don't know?Mark E Anderson
Journal of Molecular and Cellular Cardiology|December 28, 2016
CaMKII is a nodal signal for multiple programmed cell death pathways in heartNing Feng, Mark E Anderson
Pageof 21